Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Why HCA Healthcare (HCA) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
2 Stocks to Buy if There Is a Market Crash in 2025
Equity markets have been volatile over the past week as some of the industry leaders in artificial intelligence (AI) -- which make up a large percentage of indexes like the Nasdaq Composite -- have been encountering stiff competition out of China.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
These Analysts Revise Their Forecasts On HCA Healthcare Following Q4 Results
HCA Healthcare Inc. HCA reported better-than-expected earnings for its fourth quarter on Friday.
HCA Healthcare Q4 Earnings Recap: Overreaction To One-Time Event
HCA released Q4 and Full-Year FY24 earnings on Friday, January 24th beating consensus for both EPS and Revenue. Along with a strong core business, industry tailwinds are accelerating, driving greater revenue potential and mitigating cost-growth. At a DCF-generated price target of $437, 41% upside from today's pricing, I raise my rating from buy to strong buy.
HCA Healthcare's Q4 Earnings Beat Estimates on Strong Admissions
HCA's Q4 results benefit from improved equivalent admissions and inpatient surgeries, partly offset by the impact of hurricanes and higher salaries and benefits expenses.
HCA Healthcare, Inc. (HCA) Q4 2024 Earnings Call Transcript
HCA Healthcare, Inc. (NYSE:HCA ) Q4 2024 Earnings Conference Call January 24, 2025 10:00 AM ET Company Participants Frank Morgan - Vice President of Investor Relations Sam Hazen - Chief Executive Officer Mike Marks - Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank A.J. Rice - UBS Whit Mayo - Leerink Partners Ben Hendrix - RBC Capital Markets Ann Hynes - Mizuho Securities Andrew Mok - Barclays Joanna Gajuk - Bank of America Matthew Gillmor - KeyBanc Meghan Holtz - Jefferies Scott Fidel - Stephens Sarah James - Cantor Fitzgerald Jamie Perse - Goldman Sachs Ryan Langston - TD Cowen Steve Baxter - Wells Fargo Joshua Raskin - Nephron Research Lance Wilkes - Bernstein Ben Rossi - JPMorgan Operator Thank you for standing by.
HCA Healthcare Misses EPS, Revenue Up
HCA Healthcare (HCA -4.08%), an operator of healthcare facilities, released its fourth-quarter earnings for the year 2024 on January 24. In the report, it revealed a revenue total of $18.285 billion, surpassing analyst estimates of $18.234 billion.
